Carmot Therapeutics

Roche Teresa Graham Pharma Day

Biotech

Roche unveils strategy to become 'top 3' obesity company

Roche has set its sights on becoming a “top 3” obesity company, according to the pharma’s long-awaited strategy for cracking the weight loss market.

James Waldron Sep 22, 2025 8:05am

pivot change turnaround direction walk away

Roche axes Carmot obesity asset, 3 cancer drugs in R&D clear-out

Jul 24, 2025 5:00am

finance numbers tape money

Roche hopes obesity drug will show 25% weight loss one day

Sep 11, 2024 11:45am

obesity drugs

Roche’s $2.7B weight-loss wager delivers early oral GLP-1 win

Jul 17, 2024 6:00am

Photo of a final puzzle piece about to fit into a puzzle

Top 10 smartest deals in biopharma

Jun 24, 2024 6:00am

Dumbbells measuring tape and a scale on a yellow background

Roche's $2.7B Carmot bet pays off with ph. 1 weight loss success

May 16, 2024 5:29am